Analysis of the structure of T4 bacteriophage-modified valyl-tRNA synthetase by limited proteolysis and isoelectric focusing.
The new form of valyl-tRNA synthetase (EC 6.1.1.9) that appears immediately after infection of Escherichia coli with bacteriophage T4 was purified and subjected to mild proteolysis using five different proteases. The inactivation of aminoacylation activity was both more extensive and rapid than that obtained with valyl-tRNA synthetase purified from uninfected E. coli. The addition of bulk tRNA from E. coli B protected the phage-specific form of valyl-tRNA synthetase from proteolysis, but ATP and valine did not exhibit a similar protective effect. The characteristic property of phage-modified valyl-tRNA synthetase, resistance to denaturation by 4 M urea, remained unaffected during treatment with trypsin. This suggested that the phage-specific factor tau, known to be associated with the synthetase in phage-infected cells, was protected from proteolysis in the synthetase-tau complex. Comparison by isoelectric focusing of normal valyl-tRNA synthetase, the phage-specific form of this enzyme, and phage enzyme from which tau had been removed, revealed no differences in the isoelectric points of these three molecules. Based on these results a model was drawn for the structural changes occurring in valyl-tRNA synthetase after association with the phage factor tau.
D000604:Amino Acyl-tRNA Synthetases / Q000378:metabolism*; D003090:Coliphages / Q000378:metabolism*; D004926:Escherichia coli / Q000201:enzymology*; D007525:Isoelectric Focusing; D046249:Transfer RNA Aminoacylation / Q000187:drug effects; D014357:Trypsin / Q000494:pharmacology*; D014508:Urea / Q000494:pharmacology; D014637:Valine-tRNA Ligase / Q000378:metabolism*; D014764:Viral Proteins / Q000378:metabolism*
D014764:Viral Proteins; D014508:Urea; D014357:Trypsin; D000604:Amino Acyl-tRNA Synthetases; D014637:Valine-tRNA Ligase